Skip to Content

Anteris Technologies Ltd AMEUF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Anteris Technologies Ltd is an Australia-based structural heart company engaged in the sale, distribution, maintenance and implementation of infusion solutions to hospitals and health facilities. It is also involved in the manufacturing, sale and distribution of proprietary ADAPT regenerative tissue products globally; and research and development of regenerative medicine and immunotherapies. Its operating segments are Infusion business; ADAPT business; and Regenerative medicine R&D, of which it derives key revenue from the ADAPT business covering bio implant operations; inclusive of sales, distribution and manufacturing. The company derives key revenue from Australia and the U.S.

Level 3, 9 Sherwood Road, Suite 302, Toowong Tower
Toowong, QLD, 4066, Australia
T +61 731523200
Sector Healthcare
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 108